Screenless Bands, Garmin Lawsuit, Apple AI: Wearables News July 2026

Three stories are reshaping the wearables market right now: screenless fitness bands are crowding a space Whoop built almost alone, Garmin is facing legal heat over accuracy claims, and Apple is doubling down on AI health features at the risk of overpromising. None of these are minor footnotes. They affect what you buy, what you trust, and what your data actually means.

The Screenless Band Wars

Whoop has had a near-monopoly on screenless wrist wearables for serious athletes since the Whoop 4.0 launched. That is changing fast. Multiple brands are now mapping their entry into the no-screen subscription-style band space, chasing the same audience: recovery-obsessed triathletes, CrossFitters, and Hyrox athletes who want continuous optical PPG-based heart rate variability and sleep tracking without carrying a watch face. The pitch is always the same: less distraction, lighter form factor, 24/7 physiological monitoring. What separates them will come down to sensor quality and algorithm honesty. Optical PPG sensors on the wrist measure blood volume changes via reflected light, and the accuracy gap between a budget sensor and a quality one running at the same sampling rate can be 10 to 15 bpm during high-intensity intervals. That gap matters when your recovery score is built on that data.

Whoop 4.0 sets the benchmark at roughly $30/month with no upfront hardware cost. Any new entrant needs a compelling reason to switch, whether that is better skin tone calibration, longer battery life (Whoop manages around 4 to 5 days), or open data export. Athletes who have been burned by locked ecosystems should ask that question first. The Garmin Enduro 4 and similar multisport watches show there is still strong demand for screen-based wearables too, so the screenless segment remains a specific niche rather than a takeover. More on the Enduro 4 in [our recent breakdown](/en/articles/garmin-enduro-4-connect-iq-9-helio-strap-pro-what-athletes-need-to-know-2026-07-22).

Garmin Under Legal Pressure

Garmin is being sued over accuracy claims, and while the legal specifics are still unfolding, the core allegation is familiar to anyone who has tested GPS devices seriously: marketed accuracy does not always match real-world performance. GPS position accuracy depends on satellite geometry, signal multipath (urban canyons, dense tree cover), and the quality of the receiver chipset. Claiming sub-2-meter accuracy in a wristwatch during a trail run through forest is a different thing than achieving it on an open athletics track. Garmin uses multi-band GPS (combining L1 and L5 signals) on watches like the Fenix 8 and Epix Pro, which does genuinely improve accuracy vs. single-band units. But no optical sensor claim or GPS marketing figure should be taken without conditions attached.

This lawsuit is a signal to the whole industry. Polar, Coros, Suunto, and Apple all publish accuracy figures for heart rate, SpO2, and GPS that are tested under specific lab or controlled conditions. SpO2 readings from wrist-based optical sensors in particular carry wide margins of error during movement, and regulatory bodies have been slow to enforce meaningful standards. For athletes making training decisions based on these numbers, the honest answer is: use the data as a trend, not a medical measurement. If firmware issues are compounding trust problems with your current device, our [July 2026 firmware bug tracker](/en/articles/garmin-suunto-coros-firmware-bugs-july-2026-roundup-2026-07-22) is worth a read.

Apple's AI Health Gamble

Apple is pushing AI harder into the health features of watchOS and the Health app ecosystem. The ambition is real: using on-device machine learning to flag anomalies in heart rhythm data captured by the optical PPG sensor and, on Apple Watch Series 10 and Ultra 2, the electrical ECG sensor. These are two genuinely different physiologies being measured. The optical sensor reads blood volume pulse via light. The ECG electrode reads electrical activity from the heart muscle directly. Combining both with AI pattern recognition is technically interesting. The risk is that AI-generated health nudges create anxiety in healthy athletes or false confidence in those with actual conditions.

For endurance athletes specifically, Apple Watch Ultra 2 competes most directly with Garmin and Coros for running and cycling metrics, though it still lags on raw GPS battery life (around 60 hours in low-power GPS mode vs. 110 plus hours on a Coros Vertix 2S). The AI training load and recovery features are improving, but they are trained on general population data. An athlete running 100-mile weeks or doing twice-a-day swim sessions will stress-test those models in ways a casual user will not. Trust the direction of travel on AI health features. Be skeptical of individual outputs.

What is missing across all three stories is independent verification. The screenless band space lacks standardized third-party accuracy testing. The Garmin lawsuit may push for clearer disclosure but will not produce better sensors overnight. And Apple's AI health features ship without peer-reviewed validation of their athlete-specific models. The UCI ban on large bike computers is another sign that governing bodies are trying to catch up with hardware that has outpaced regulation. These are not product failures. They are growing pains for an industry moving faster than its accountability structures.

The verdict: if you are a serious endurance athlete shopping in mid-2026, the screenless band space is worth watching but not worth abandoning a quality multisport watch for yet. The Garmin lawsuit is background noise for now, but it should make you read marketing claims more carefully. Apple Watch Ultra 2 is a legitimate training tool with real limitations on battery and ecosystem depth. Whatever you pick, cross-reference the sensor specs, ask what the data is actually measuring, and treat recovery scores as directional indicators rather than ground truth.